CureVac N.V. Total Non Current Liabilities 2011-2026 | CVAC

Annual Total Non Current Liabilities CureVac N.V.

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
112 M	552 M	145 M	65.4 M	-	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
552 M	65.4 M	219 M

Quarterly Total Non Current Liabilities CureVac N.V.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	107 M	114 M	112 M	154 M	-	-	552 M	-	-	-	145 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
552 M	107 M	197 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	79.1 K	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	158 K	-	1.35 %	$ 17.8 M	China
Amphastar Pharmaceuticals AMPH	69.4 M	$ 16.93	-2.14 %	$ 791 M	USA
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
AstraZeneca PLC AZN	34.7 B	-	-	$ 96.9 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Arcturus Therapeutics Holdings ARCT	30.4 M	$ 7.45	-4.85 %	$ 204 M	Israel
Athira Pharma ATHA	876 K	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	7.32 M	-	0.74 %	$ 768 M	Israel
Galera Therapeutics GRTX	64 M	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	645 K	-	-18.52 %	$ 27.3 M	Britain
AbCellera Biologics ABCL	326 M	$ 4.09	-7.16 %	$ 1.22 B	Canada
Coherus BioSciences CHRS	189 M	$ 1.57	-3.68 %	$ 184 M	USA
Autolus Therapeutics plc AUTL	50.6 M	$ 1.62	1.76 %	$ 431 M	Britain
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
BioNTech SE BNTX	622 M	$ 89.73	-2.46 %	$ 21.7 B	Germany
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	1.19 M	$ 3.38	-3.15 %	$ 5.56 M	Israel
Aeterna Zentaris AEZS	14 M	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Enlivex Therapeutics Ltd. ENLV	383 M	$ 0.73	-0.15 %	$ 33.4 M	Israel
Eton Pharmaceuticals ETON	4.56 M	$ 29.89	-0.23 %	$ 804 M	USA
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Esperion Therapeutics ESPR	355 M	$ 3.13	0.16 %	$ 651 M	USA
Aptose Biosciences APTO	27.9 M	-	-45.71 %	$ 1.2 M	Canada
Exelixis EXEL	63.6 M	$ 50.21	-1.74 %	$ 13.6 B	USA
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	8.11 M	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	167 M	$ 21.61	0.19 %	$ 2.75 B	USA
Allena Pharmaceuticals ALNA	10.2 M	-	3.16 %	$ 1.9 M	USA
Fortress Biotech FBIO	83.9 M	$ 2.42	5.0 %	$ 67.5 M	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Forte Biosciences FBRX	10.5 M	$ 22.57	-5.8 %	$ 292 M	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
Fennec Pharmaceuticals FENC	24.6 M	$ 9.66	4.6 %	$ 276 M	USA
Aileron Therapeutics ALRN	4.59 M	-	10.36 %	$ 9.8 M	USA
Applied Therapeutics APLT	797 K	-	-	$ 8.42 M	USA